Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma. [electronic resource] by
- Fenton, R G
- Steis, R G
- Madara, K
- Zea, A H
- Ochoa, A C
- Janik, J E
- Smith, J W
- Gause, B L
- Sharfman, W H
- Urba, W J
- Hanna, M G
- DeJager, R L
- Coyne, M X
- Crouch, R D
- Gray, P
- Beveridge, J
- Creekmore, S P
- Holmlund, J
- Curti, B D
- Sznol, M
- Longo, D L
Producer: 19970303
In:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy vol. 19
Availability: No items available.
|